Cargando…
CDK4 is an essential insulin effector in adipocytes
Autores principales: | Lagarrigue, Sylviane, Lopez-Mejia, Isabel C., Denechaud, Pierre-Damien, Escoté, Xavier, Castillo-Armengol, Judit, Jimenez, Veronica, Chavey, Carine, Giralt, Albert, Lai, Qiuwen, Zhang, Lianjun, Martinez-Carreres, Laia, Delacuisine, Brigitte, Annicotte, Jean-Sébastien, Blanchet, Emilie, Huré, Sébastien, Abella, Anna, Tinahones, Francisco J., Vendrell, Joan, Dubus, Pierre, Bosch, Fatima, Kahn, C. Ronald, Fajas, Lluis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246374/ https://www.ncbi.nlm.nih.gov/pubmed/35775487 http://dx.doi.org/10.1172/JCI162359 |
Ejemplares similares
-
CDK4 is an essential insulin effector in adipocytes
por: Lagarrigue, Sylviane, et al.
Publicado: (2023) -
E2F1 promotes hepatic gluconeogenesis and contributes to hyperglycemia during diabetes
por: Giralt, Albert, et al.
Publicado: (2018) -
CDK4, pRB and E2F1: connected to insulin
por: Fajas, Lluis, et al.
Publicado: (2010) -
CDK7 Mediates the Beta-Adrenergic Signaling in Thermogenic Brown and White Adipose Tissues
por: Ji, Honglei, et al.
Publicado: (2020) -
E2F1, a Novel Regulator of Metabolism
por: Denechaud, Pierre-Damien, et al.
Publicado: (2017)